WeRide (WRD) Targets Right Hand Drive Robotaxis, Is 49% Below Fair Value?

WeRide Inc. Sponsored ADR

WeRide Inc. Sponsored ADR

WRD

0.00

Right-hand-drive robotaxi partnership puts WeRide (WRD) in focus

WeRide (WRD) is drawing attention after announcing a partnership with Geely Farizon and Kwoon Chung Bus Holdings to design and mass-produce right-hand-drive robotaxis, with initial deployment planned in Hong Kong.

The collaboration targets markets such as Singapore, the UK, Japan, and Australia, where there is currently a shortage of autonomous options tailored for right-hand-drive traffic systems.

At a share price of $5.57, WeRide has seen its short-term momentum soften, with the 30-day share price return down 8.69% and the year-to-date share price return down 40.68%, while the 1-year total shareholder return is down 34.78%. This suggests the right-hand-drive robotaxi news is arriving against a backdrop of weaker sentiment that could reflect shifting views on risk and execution.

If WeRide’s right-hand-drive push has you looking across autonomous and automation themes, it could be worth scanning other opportunities with our robotics and automation stock screener via 30 robotics and automation stocks.

WeRide is pitching a broad autonomous platform, from robotaxis to sanitation vehicles, into a market that has recently marked the stock down. The next step is weighing whether that story is already fully reflected in today’s share price.

Most Popular Narrative: 49.5% Undervalued

Against WeRide’s last close of $5.57, the most followed narrative anchors on a Fair Value of $11.02, built using a 9.0% discount rate and detailed long range forecasts.

While the industry is structurally shifting toward software defined vehicles and autonomous mobility platforms, WeRide’s sustained high R&D intensity and global compliance costs may outpace near term monetization. This could keep adjusted net losses elevated even as headline revenue grows strongly.

Want to see what justifies that Fair Value gap for WeRide? The narrative leans on rapid revenue expansion, shifting margins and a future earnings multiple usually reserved for market leaders.

Result: Fair Value of $11.02 (UNDERVALUED)

However, WeRide’s deeply loss making profile and heavy reliance on partners for distribution and fleet deployment could still challenge the bearish undervalued narrative if execution falters.

Another view on WeRide’s valuation

The earlier fair value work for WeRide leans on analyst forecasts and long range earnings assumptions. By contrast, the current P/S of 17.1x is far above the estimated fair ratio of 4.2x, the US Auto Components industry at 0.6x and peer average at 0.8x, which points to meaningful valuation risk if sentiment cools or revenue timing disappoints. Which story do you think better reflects the risk you are taking?

For readers who want to see how this pricing gap looks through a single valuation lens, it is worth walking through the detailed breakdown in our ratio based assessment, including how it compares with similar stocks and the fair ratio the market could move toward over time, via See what the numbers say about this price — find out in our valuation breakdown..

NasdaqGM:WRD P/S Ratio as at Jul 2026
NasdaqGM:WRD P/S Ratio as at Jul 2026

Next Steps

With sentiment on WeRide clearly mixed, it makes sense to move quickly, review the underlying data and decide where you stand. To see how the potential upside compares with the concerns investors are flagging, take a closer look at the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond WeRide?

If you are weighing WeRide and want a broader watchlist, use the Simply Wall St screener to spot other stocks that better match your risk and return preferences.

  • Target potential mispricing by reviewing companies that appear attractively valued on fundamentals through the 44 high quality undervalued stocks.
  • Strengthen your income focus by scanning for companies with higher yields using the 9 dividend fortresses.
  • Prioritize resilience by checking companies that score well on financial health with the solid balance sheet and fundamentals stocks screener (47 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.